Roche Diagnostics and Exiqon A/S, Vedbæk, Denmark, a provider of high-value gene expression analysis products, announced that they have entered into a license agreement for use of SYBR Green reagent in PCR. Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in Real Time PCR. SYBR Green provides the simplest and most economical format for detecting and quantitating PCR products in Real-Time PCR reactions. Financial terms of the agreement were not disclosed.
"From our view, the licensing of the use of SYBR Green reagent in Real Time PCR reaction is an important contribution to further developing the PCR technology in the life science field," states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
Roche and Exiqon signed an amendment to their 2005 license and distribution agreement for Exiqon's Universal ProbeLibrary (UPL) already some weeks ago.
"From our view, the licensing of the use of SYBR Green reagent in Real Time PCR reaction is an important contribution to further developing the PCR technology in the life science field," states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
Roche and Exiqon signed an amendment to their 2005 license and distribution agreement for Exiqon's Universal ProbeLibrary (UPL) already some weeks ago.
